These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 22938842

  • 21. Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study.
    Ludwig VM, Sauer C, Young AH, Rucker J, Bauer M, Findeis H, Ritter P.
    CNS Drugs; 2021 Aug; 35(8):881-892. PubMed ID: 34283390
    [Abstract] [Full Text] [Related]

  • 22. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA.
    Ned Tijdschr Geneeskd; 2003 Oct 04; 147(40):1940-3. PubMed ID: 14574774
    [Abstract] [Full Text] [Related]

  • 23. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT.
    J Am Geriatr Soc; 2007 Nov 04; 55(11):1890. PubMed ID: 17979910
    [No Abstract] [Full Text] [Related]

  • 24. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G, Finberg JP, Youdim MB.
    Clin Neuropharmacol; 1993 Nov 04; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological treatment of frontotemporal dementia: treatment response to the MAO-A inhibitor moclobemide.
    Adler G, Teufel M, Drach LM.
    Int J Geriatr Psychiatry; 2003 Jul 04; 18(7):653-5. PubMed ID: 12833310
    [No Abstract] [Full Text] [Related]

  • 26. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP, Tsoi WF.
    Singapore Med J; 1995 Feb 04; 36(1):38-40. PubMed ID: 7570133
    [Abstract] [Full Text] [Related]

  • 27. Cardiac myonecrosis in hypertensive crisis associated with monoamine oxidase inhibitor therapy.
    Liu LX, Rustgi AK.
    Am J Med; 1987 May 04; 82(5):1060-4. PubMed ID: 3578343
    [Abstract] [Full Text] [Related]

  • 28. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI, Herrmann N, Walker SE.
    CNS Drugs; 2013 Oct 04; 27(10):789-97. PubMed ID: 23934742
    [Abstract] [Full Text] [Related]

  • 29. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ, Sanz-Carrillo C, Ferrández Payo M.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995 Oct 04; 23(4):217-22. PubMed ID: 7484306
    [Abstract] [Full Text] [Related]

  • 30. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study.
    Versiani M, Amrein R, Montgomery SA.
    Int Clin Psychopharmacol; 1997 Sep 04; 12(5):239-54. PubMed ID: 9466158
    [Abstract] [Full Text] [Related]

  • 31. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I, Spigset O.
    Tidsskr Nor Laegeforen; 2009 Apr 16; 129(8):746-8. PubMed ID: 19373300
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA.
    Clin Neuropharmacol; 1993 Apr 16; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tranylcypromine, but not moclobemide, prolongs the inhibitory action of dopamine on midbrain dopaminergic neurons: an in vitro electrophysiological study.
    Mercuri NB, Federici M, Marinelli S, Bernardi G.
    Synapse; 2000 Sep 01; 37(3):216-21. PubMed ID: 10881043
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Spontaneous hypertensive reactions with monoamine oxidase inhibitors.
    Lavin MR, Mendelowitz A, Kronig MH.
    Biol Psychiatry; 1993 Aug 01; 34(3):146-51. PubMed ID: 8399806
    [Abstract] [Full Text] [Related]

  • 40. Myocardial Injury from Tranylcypromine-Induced Hypertensive Crisis Secondary to Excessive Tyramine Intake.
    Salter M, Kenney A.
    Cardiovasc Toxicol; 2018 Dec 01; 18(6):583-586. PubMed ID: 30083815
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.